Myron Z Holubiak
CIK 1199080 · Secretary · last filed 2025-12-22
Myron Z Holubiak is a Secretary who has filed 54 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CTOR, was dated Dec 22, 2025. Across all open-market trades the lifetime net is +$652.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $601.7K across reported positions. 20 SEC filings were submitted jointly with Citius Pharmaceuticals, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CTXRW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
11 COMMERCE DRIVE, FIRST FLOOR
CRANFORD, NJ 07016
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTOR | Secretary | 950,000 | $0.60 | $565.9K | $0 | 5 | 2025-12-22 |
| CTXR | Vice Chairman | 79,690 | $0.45 | $35.8K | $0 | 6 | 2025-08-12 |
| Citius Pharmaceuticals, Inc. (CTXRW) Delisted | President and CEO | 1,992,243 | $0.14 | $287.1K | $1.71M | 10 | 2021-10-13 |
| ASMB | Director | — | $19.67 | — | $0 | 9 | 2021-05-24 |
| Option Care Health, Inc. (BIOS) Delisted | Director | 40,000 | $10.79 | $431.8K | -$1.01M | 17 | 2016-06-02 |
| ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted | Director | — | — | — | $0 | 3 | 2014-07-14 |
| Adhera Therapeutics, Inc. (NSTK) Delisted | Director | 26,657 | — | — | -$42.6K | 2 | 2007-08-16 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-22 | CTOR | Grant (A) | +850,000 | $0 | EDGAR |
| 2025-12-01 | CTOR | Grant (A) | +850,000 | $0 | EDGAR |
| 2025-09-23 | CTOR | Grant (A) | +950,000 | $0 | EDGAR |
| 2025-08-12 | CTXR | Mixed | — | $0 | EDGAR |
| 2024-12-16 | CTOR | Grant (A) | — | $0 | EDGAR |
| 2024-11-12 | CTXR | Grant (A) | — | $0 | EDGAR |
| 2024-09-27 | CTXR | Mixed | — | $0 | EDGAR |
| 2024-08-30 | CTOR | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | — | Grant (A) | — | $0 | |
| 2024-04-05 | CTXR | Mixed | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.